Work

Safety, Pharmacokinetics, and Antitumor Activity of AMG 386, a Selective Angiopoietin Inhibitor, in Adult Patients With Advanced Solid Tumors

Year: 2009

Type: article

Study design: Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2008.19.6683

Authors: Roy S. Herbst, David Hong, Linnea Chap, Razelle Kurzrock, Edward Jackson, Jeffrey M. Silverman, Erik Rasmussen, Yu-Nien Sun, Don Zhong, Yuying C. Hwang, Jeffrey L. Evelhoch, Jonathan D. Oliner, NgocDiep Le, Lee S. Rosen

Institutions: Amgen (United States), The University of Texas MD Anderson Cancer Center

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2122927195

FWCI: 12.87

Cites: 34

Cited by: 241

Related to: 10